Company Successfully Completes First Ever FDA Pivotal Study for Skin Cancer Detection Device for Primary Care
MIAMI, FLORIDA, UNITED STATES, June 15, 2022 /EINPresswire.com/ Miami-Based DermaSensor, Inc. Raises Additional $10 Million To Prepare for U.S. Launch DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) …